ATE342970T1 - Verwendung eines menschlichen interleukin-11 rezeptors - Google Patents

Verwendung eines menschlichen interleukin-11 rezeptors

Info

Publication number
ATE342970T1
ATE342970T1 AT95942913T AT95942913T ATE342970T1 AT E342970 T1 ATE342970 T1 AT E342970T1 AT 95942913 T AT95942913 T AT 95942913T AT 95942913 T AT95942913 T AT 95942913T AT E342970 T1 ATE342970 T1 AT E342970T1
Authority
AT
Austria
Prior art keywords
receptor
human interleukin
human
disclosed
methods
Prior art date
Application number
AT95942913T
Other languages
English (en)
Inventor
James F Tobin
Original Assignee
Genetics Inst Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst Llc filed Critical Genetics Inst Llc
Application granted granted Critical
Publication of ATE342970T1 publication Critical patent/ATE342970T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT95942913T 1994-12-22 1995-11-27 Verwendung eines menschlichen interleukin-11 rezeptors ATE342970T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36230494A 1994-12-22 1994-12-22

Publications (1)

Publication Number Publication Date
ATE342970T1 true ATE342970T1 (de) 2006-11-15

Family

ID=23425547

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95942913T ATE342970T1 (de) 1994-12-22 1995-11-27 Verwendung eines menschlichen interleukin-11 rezeptors

Country Status (10)

Country Link
US (2) US6528281B1 (de)
EP (2) EP1566440A3 (de)
JP (2) JPH10511266A (de)
AT (1) ATE342970T1 (de)
AU (1) AU717928B2 (de)
CA (1) CA2208457A1 (de)
DE (1) DE69535274T2 (de)
DK (1) DK0797664T3 (de)
ES (1) ES2275268T3 (de)
WO (1) WO1996019574A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0804576B1 (de) * 1994-09-05 2008-09-03 Amrad Operations Pty.,Ltd. Hemopoietin-rezeptor
CA2237915A1 (en) 1998-05-19 1999-11-19 Stephen Shaughnessy Osteoporosis treatment
US6953777B2 (en) 1999-03-11 2005-10-11 Genetics Indtitute LLC Use of interleukin-11 to prevent immune-mediated cytotoxicity
US20050074747A1 (en) * 2000-09-08 2005-04-07 Wadih Arap Biopanning and rapid analysis of selective interactive ligands (brasil)
US7452964B2 (en) * 2001-09-07 2008-11-18 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides against placenta and adipose tissues
US7420030B2 (en) 2000-09-08 2008-09-02 The Board Of Regents Of The University Of Texas System Aminopeptidase A (APA) targeting peptides for the treatment of cancer
US20040170955A1 (en) * 2000-09-08 2004-09-02 Wadih Arap Human and mouse targeting peptides identified by phage display
EP1418932A4 (de) * 2001-07-18 2006-03-15 Univ Texas Antiangiogener zustand bei mäusen und menschen mit retinaler photorezeptor-degeneration
US7671010B2 (en) * 2002-08-30 2010-03-02 The Board Of Regents Of The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
US8507445B2 (en) * 2001-09-07 2013-08-13 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
US20040048243A1 (en) * 2001-09-07 2004-03-11 Wadih Arap Methods and compositions for in vitro targeting
US6982080B2 (en) 2002-03-15 2006-01-03 Wyeth Hydroxyethyl starch—containing polypeptide compositions
WO2005065418A2 (en) * 2003-12-31 2005-07-21 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides for diagnosis and therapy
EP1598364A1 (de) * 2004-05-21 2005-11-23 AGIRx Limited Chimerischer löslicher Hyper IL-11 Rezeptor und dessen Verwendung
JP6959274B2 (ja) * 2013-02-07 2021-11-02 シーエスエル、リミテッド Ｉｌ−１１ｒ結合タンパク質及びその使用
CN117843785A (zh) * 2013-02-07 2024-04-09 Csl有限公司 Il-11r结合蛋白及其应用
GB201522186D0 (en) 2015-12-16 2016-01-27 Singapore Health Services Pte Ltd And Nat University Of Singapore The Treatment of fibrosis
GB201621439D0 (en) 2016-12-16 2017-02-01 Singapore Health Services Pte Ltd And Nat Univ Of Singapore IL-11Ra Antibodies
GB201621431D0 (en) * 2016-12-16 2017-02-01 Singapore Health Services Pte Ltd And Nat Univ Of Singapore The Decoy cytokine receptor
US20180186871A1 (en) 2016-12-16 2018-07-05 Singapore Health Services Pte Ltd. Il-11 antibodies
EP3914621A1 (de) 2019-01-21 2021-12-01 Singapore Health Services Pte. Ltd. Behandlung von hepatotoxizität
US12343336B2 (en) 2019-08-05 2025-07-01 Novocure Gmbh Increasing cancer cells' sensitivity to tumor treating fields (TTFields) by inhibiting IL11 activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215895A (en) 1989-11-22 1993-06-01 Genetics Institute, Inc. Dna encoding a mammalian cytokine, interleukin-11
US5270181A (en) 1991-02-06 1993-12-14 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US5292646A (en) 1991-02-06 1994-03-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
EP0804576B1 (de) * 1994-09-05 2008-09-03 Amrad Operations Pty.,Ltd. Hemopoietin-rezeptor

Also Published As

Publication number Publication date
AU717928B2 (en) 2000-04-06
EP0797664B1 (de) 2006-10-18
DK0797664T3 (da) 2007-01-22
JP2006246890A (ja) 2006-09-21
AU4410096A (en) 1996-07-10
US6350855B1 (en) 2002-02-26
DE69535274T2 (de) 2007-06-06
EP1566440A3 (de) 2005-10-19
US6528281B1 (en) 2003-03-04
WO1996019574A1 (en) 1996-06-27
EP1566440A2 (de) 2005-08-24
JPH10511266A (ja) 1998-11-04
ES2275268T3 (es) 2007-06-01
MX9704618A (es) 1997-09-30
DE69535274D1 (de) 2006-11-30
EP0797664A1 (de) 1997-10-01
CA2208457A1 (en) 1996-06-27

Similar Documents

Publication Publication Date Title
ATE342970T1 (de) Verwendung eines menschlichen interleukin-11 rezeptors
DK169689D0 (da) Polygonal informationsindkodningsmaerkning, fremgangsmaade ved indkodning og aflaesning af information og anlaeg til udoevelse af fremgangsmaaden
EP0680643A4 (de) Gerat und verfahren zur datenkompression.
DE69713295D1 (de) Azabicyclishe carbaniumsaureester zur therapeutsichen verwendung
DE69520924D1 (de) Vorrichtung zur Rekodierung von kodierten Bilddaten
MY121185A (en) Recombinant antibodies for human therapy.
DE69621862D1 (de) Skalainvarianz mittels Karhunem-Loeve-Transformation zur Gesichtserkennung
ATE222774T1 (de) Antikörper gegen cd 18 zur verwendung gegen gehirnschlag
EP0613303A3 (de) Vorrichtung und Verfahren zur Kompression von Bildsignalen.
FI954292L (fi) Fosforilla muunnettuja epoksihartseja, menetelmä niiden valmistamiseksi ja niiden käyttö
DE69841607D1 (de) Menschliche Toll-Homologe
DE69618436D1 (de) Vorrichtung zur Herstellung von Taschenschraubenfedern
DE69109809D1 (de) Vorrichtung zur Beseitigung von Blattwellungen.
FI954291A0 (fi) Fosforilla muunnettuja epoksihartseja, menetelmä niiden valmistamiseksi ja niiden käyttö
DE69840203D1 (de) Vefahren zur Datenkompression
IT8921459A0 (it) Procedimento e dispositivo per impostare un processo di piegatura, nonche' procedimento per la preparazione di dati di piegatura.
DE69119936D1 (de) Einrichtung zur Datenkompression
DE69933696D1 (de) Cytokinrezeptor-kette
NO976094D0 (no) Nye peptider avledet av humant varmesjokkprotein 60 for behandling av diabetes, fremgangsmåte og sett
EP0982271A4 (de) Verfahren zum biegen von flachglas, ring form zum biegen von flachglas und vorrichtung dafür
AR002384A1 (es) Método para preparar ureas cíclicas asimétricas n-sustituidas y n,n' disustituidas
DE59600130D1 (de) Vorrichtung zur Versorgung von Knochenbrüchen
DE69507747D1 (de) Vorrichtung zur Aufzeichnung von komprimierter Bildinformation
PT744027E (pt) Utilizacao de metodos para identificar oligopeptidos de sinal hidrofilicos
DE69523248D1 (de) Vorrichtung zur Kodierung/Dekodierung von Bildinformation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties